Inhibition of LPS-induced TNFα production in human monocytes by adenosine (A2) receptor selective agonists
- 31 March 1995
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 17 (3) , 221-224
- https://doi.org/10.1016/0192-0561(94)00096-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitorInternational Journal of Immunopharmacology, 1994
- Protective effect of an adenosine kinase inhibitor in septic shock.The Journal of Immunology, 1994
- Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge.The Journal of Immunology, 1993
- Inhibition of CD44, CD45 and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifyllineInternational Journal of Immunopharmacology, 1993
- The selective adenosine A2 receptor agonist, CGS 21680, is a potent depressant of cerebral cortical neuronal activityBrain Research, 1990
- 3,7-Dimethyl-1-propargylxanthine: A potent and selective in vivo antagonist of adenosine analogsLife Sciences, 1988
- Regulation of macrophage tumor necrosis factor production by prostaglandin E2Biochemical and Biophysical Research Communications, 1986
- Nomenclature of adenosine receptorsTrends in Pharmacological Sciences, 1985
- Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytesBiochemical Journal, 1984
- Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotidesNature, 1979